Appendix 4D and Half Year Accounts
| Stock | Ecofibre Ltd (EOF.ASX) |
|---|---|
| Release Time | 19 Feb 2025, 9:40 a.m. |
| Price Sensitive | Yes |
Ecofibre reports H1 2025 results
- Revenue decreased 8% to $12.8m
- Net loss reduced 61% to $17.7m
- Focused on core businesses, reducing costs and debt
Ecofibre Limited reported a 61% reduction in net loss for the first half of 2025, despite an 8% decline in revenue. The company continued to focus on its core businesses, reduce operating costs, and restructure debt to improve its financial position. Key highlights include: 1) Decision to sell the Ecofibre Genetics business, 2) Commenced a strategic review of the Ananda Health business, 3) Reduced operating costs by 10% compared to the prior period, 4) Completed a sale and leaseback of properties in the US, enabling repayment of $9m in secured debt, 5) Signed new working capital facilities to improve liquidity, and 6) Restructured existing unsecured loans to extend repayment terms. The company's Ecofibre Advanced Technologies (EAT) business, the key growth engine, delivered a small EBITDA profit in the period with improvements in revenue, gross margin and operating costs. The company also continues to focus on realizing value from its EOF Bio life sciences business.